Avicanna Inc. (AVCNF)
OTCMKTS
· Delayed Price · Currency is USD
0.203
0.00 (0.00%)
Dec 24, 2024, 3:00 PM EST
Avicanna Market Cap
Avicanna has a market cap or net worth of $24.51 million as of December 26, 2024. Its market cap has decreased by -24.36% in one year.
Market Cap
24.51M
Enterprise Value
29.30M
Revenue
18.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
Market Cap Chart
Since July 18, 2019, Avicanna's market cap has decreased from 104.82M to 24.51M, a decrease of -76.62%. That is a compound annual growth rate of -23.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 24, 2024 | 24.51M | 2.00% |
Dec 29, 2023 | 24.03M | 5.84% |
Dec 30, 2022 | 22.71M | -19.71% |
Dec 31, 2021 | 28.28M | -26.61% |
Dec 31, 2020 | 38.54M | -11.73% |
Dec 31, 2019 | 43.66M | -58.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sandoz Group AG | 18.07B |
Telix Pharmaceuticals Limited | 5.22B |
Elekta AB (publ) | 2.09B |
Ryman Healthcare Limited | 1.72B |
Verano Holdings Corp. | 443.32M |
Vireo Growth Inc. | 131.25M |
Medexus Pharmaceuticals Inc. | 55.68M |